Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series

Madison Kolbow; Jade Cohen; Saranya Prathibha; Schelomo Marmor; Marie Claire Buckley; Jane Yuet Ching Hui

doi:10.1089/trgh.2023.0011

Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series

Madison Kolbow, Jade Cohen, Saranya Prathibha, Schelomo Marmor, Marie Claire Buckley, Jane Yuet Ching Hui

Surgery

Research output: Contribution to journal › Article › peer-review

Abstract

This retrospective study investigated the incidence of breast atypia and breast cancer (BC) in patients undergoing chest masculinization surgery. Of the 880 patients included, 7 (0.8%) were diagnosed with atypia and none with BC. The median age at surgery for patients without and with atypia was 25.0 and 36.0 years, respectively. Preoperative testosterone therapy utilization was similar among patients with atypia (71%) and patients without (79%). No patients with atypia were diagnosed with subsequent BC during a median follow-up of 37 months. Appropriate BC screening and risk management for patients undergoing chest masculinization surgery should be further elucidated.

Original language	English (US)
Journal	Transgender Health
DOIs	https://doi.org/10.1089/trgh.2023.0011
State	Accepted/In press - 2023

Bibliographical note

Publisher Copyright:
© Mary Ann Liebert, Inc.

Keywords

breast atypia
breast cancer
gender-affirming surgery
top surgery
transgender

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1089/trgh.2023.0011

Cite this

@article{8ba9f4a4323441a3b97e37c48c4f7294,

title = "Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series",

abstract = "This retrospective study investigated the incidence of breast atypia and breast cancer (BC) in patients undergoing chest masculinization surgery. Of the 880 patients included, 7 (0.8%) were diagnosed with atypia and none with BC. The median age at surgery for patients without and with atypia was 25.0 and 36.0 years, respectively. Preoperative testosterone therapy utilization was similar among patients with atypia (71%) and patients without (79%). No patients with atypia were diagnosed with subsequent BC during a median follow-up of 37 months. Appropriate BC screening and risk management for patients undergoing chest masculinization surgery should be further elucidated.",

keywords = "breast atypia, breast cancer, gender-affirming surgery, top surgery, transgender",

author = "Madison Kolbow and Jade Cohen and Saranya Prathibha and Schelomo Marmor and Buckley, {Marie Claire} and Hui, {Jane Yuet Ching}",

note = "Publisher Copyright: {\textcopyright} Mary Ann Liebert, Inc.",

year = "2023",

doi = "10.1089/trgh.2023.0011",

language = "English (US)",

journal = "Transgender Health",

issn = "2380-193X",

publisher = "Mary Ann Liebert Inc.",

}

TY - JOUR

T1 - Incidental Atypia in Patients Undergoing Chest Masculinization Surgery

T2 - An Observational Series

AU - Kolbow, Madison

AU - Cohen, Jade

AU - Prathibha, Saranya

AU - Marmor, Schelomo

AU - Buckley, Marie Claire

AU - Hui, Jane Yuet Ching

N1 - Publisher Copyright: © Mary Ann Liebert, Inc.

PY - 2023

Y1 - 2023

N2 - This retrospective study investigated the incidence of breast atypia and breast cancer (BC) in patients undergoing chest masculinization surgery. Of the 880 patients included, 7 (0.8%) were diagnosed with atypia and none with BC. The median age at surgery for patients without and with atypia was 25.0 and 36.0 years, respectively. Preoperative testosterone therapy utilization was similar among patients with atypia (71%) and patients without (79%). No patients with atypia were diagnosed with subsequent BC during a median follow-up of 37 months. Appropriate BC screening and risk management for patients undergoing chest masculinization surgery should be further elucidated.

AB - This retrospective study investigated the incidence of breast atypia and breast cancer (BC) in patients undergoing chest masculinization surgery. Of the 880 patients included, 7 (0.8%) were diagnosed with atypia and none with BC. The median age at surgery for patients without and with atypia was 25.0 and 36.0 years, respectively. Preoperative testosterone therapy utilization was similar among patients with atypia (71%) and patients without (79%). No patients with atypia were diagnosed with subsequent BC during a median follow-up of 37 months. Appropriate BC screening and risk management for patients undergoing chest masculinization surgery should be further elucidated.

KW - breast atypia

KW - breast cancer

KW - gender-affirming surgery

KW - top surgery

KW - transgender

UR - http://www.scopus.com/inward/record.url?scp=85182229482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182229482&partnerID=8YFLogxK

U2 - 10.1089/trgh.2023.0011

DO - 10.1089/trgh.2023.0011

M3 - Article

AN - SCOPUS:85182229482

SN - 2380-193X

JO - Transgender Health

JF - Transgender Health

ER -

Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series

Abstract

Bibliographical note

Keywords

UN SDGs

Access

Other files and links

Fingerprint

Cite this